Cost-effectiveness of nurse-led home monitoring of serum urate for gout patients starting with urate-lowering therapy in secondary care: a modeling study
Open Access
- 16 July 2025
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 74, 152782
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With GoutJAMA, 2022
- Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trialThe Lancet Rheumatology, 2022
- Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision ModelersPharmacoEconomics, 2020
- The economic burden of uncontrolled gout: how controlling gout reduces costJournal of Medical Economics, 2018
- Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trialThe Lancet, 2018
- Medication adherence among patients with gout: A systematic review and meta-analysisSeminars in Arthritis and Rheumatism, 2018
- GoutThe Lancet, 2016
- Factors associated with access to rheumatologists for Medicare patientsSeminars in Arthritis and Rheumatism, 2016
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trialArthritis Care & Research, 2008
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutNew England Journal of Medicine, 2005